Expiration date: 08/2025

Release form

Concentrate for solution for infusion

Composition

1 ml of solution contains:

Active substance: potassium chloride 40 mg.

Excipients: dextrose, hydrochloric acid (hydrochloric acid 0.1 M), water for injection.

Packaging

10 PCs

10 PCs

Pharmacological action

POTASSIUM CHLORIDE BUFUS drug, restores the water-electrolyte balance. Has a negative Chrono - and batmotropnoe action, at high doses, negative Ino - and Chrono dromotroponoe, and a moderate diuretic effect. In small doses, K+ dilates coronary vessels, large - narrow. Involved in the process of conducting nerve impulses. Intravenous administration increases the secretion of epinephrine by the adrenal glands.

Activates a cytoplasmic enzyme, is involved in maintaining intracellular osmotic pressure in protein-synthesis reactions and the transport of amino acids. Improves the contraction of skeletal muscles in muscular dystrophy, myasthenia gravis. Increasing the concentration of K+ reduces the risk of toxic cardiac glycosides.

Testimony

Hypokalemia (including diabetes mellitus, prolonged diarrhea and/or vomiting, therapy of antihypertensive drugs, certain diuretics, corticosteroids), treatment and prevention digitalisnaya intoxication, prevention of arrhythmia in patients with myocardial infarction (acute period).

Contraindications

Hyperkalemia, atrioventricular block complete, adrenal insufficiency, chronic renal insufficiency, concomitant therapy with potassium-sparing diuretics, metabolic disturbances (acidosis, hypovolemia with hyponatremia), pregnancy, lactation, age to 18 years (efficacy and safety not established).

Application of pregnancy and breastfeeding

If necessary, use during pregnancy should weigh the expected benefit to the mother and the potential risk to the fetus, lactation should decide the issue of termination of breastfeeding.